Floatz logo

ASPARAGINASE

Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies

Children's Oncology Groupprotein_peptidePhase 3Dormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Children's Oncology Group
Phase 3BBB
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Joanna Yi
Phase 3BBB
Daunorubicin
Princess Maxima Center for Pediatric Oncology
Phase 3BBB
THIOGUANINE ANHYDROUS
Grupo Argentino de Tratamiento de la Leucemia Aguda
Phase 3BB
PEGASPARGASE
Children's Oncology Group
Phase 3BB

View all 9 →

Same molecule, other indications

ASPARAGINASE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →